Evidence map›Paper›PMID 36158271›Full record

ArticleWorld journal of gastroenterology2022

Accumulation of poly (adenosine diphosphate-ribose) by sustained supply of calcium inducing mitochondrial stress in pancreatic cancer cells.

Keun-Yeong Jeong, Jae Jun Sim, Minhee Park, Hwan Mook Kim

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Keun-Yeong JeongResearch and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea. alvirus@naver.com.
Jae Jun SimResearch and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea.
Minhee ParkResearch and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea.
Hwan Mook KimResearch and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe biochemical phenomenon defined as poly adenosine diphosphate (ADP)-ribosylation (PARylation) is essential for the progression of pancreatic cancer. However, the excessive accumulation of poly ADP-ribose (PAR) induces apoptosis-inducing factor (AIF) release from mitochondria and energy deprivation resulting in the caspase-independent death of cancer cells.

aimTo investigate whether sustained calcium supply could induce an anticancer effect on pancreatic cancer by PAR accumulation.

methodsTwo pancreatic cancer cell lines, AsPC-1 and CFPAC-1 were used for the study. Calcium influx and mitochondrial reactive oxygen species (ROS) were observed by fluorescence staining. Changes in enzyme levels, as well as PAR accumulation and energy metabolism, were measured using assay kits. AIF-dependent cell death was investigated followed by confirming

resultsMitochondrial ROS levels were elevated with increasing calcium influx into pancreatic cancer cells. Then, excess PAR accumulation, decreased PAR glycohydrolase and ADP-ribosyl hydrolase 3 levels, and energy deprivation were observed.

conclusionThis study visualized the potential anticancer effects of excessive PAR accumulation by sustained calcium supply on pancreatic cancer, however elucidating a clear mode of action remains a challenge, and it should be accompanied by further studies to assess its potential for clinical application.

Indexed as

Pancreatic NeoplasmsPoly Adenosine Diphosphate RiboseAdenosine DiphosphateApoptosis Inducing FactorCalciumCaspasesGlycoside HydrolasesHumansMitochondriaReactive Oxygen SpeciesRiboseAdenosine DiphosphateApoptosis Inducing FactorCalciumCaspasesGlycoside HydrolasesPoly Adenosine Diphosphate RiboseReactive Oxygen SpeciesRiboseAnticancer effectApoptosis-inducing factorCalciumNicotinamide adenine dinucleotidePancreatic cancerPoly adenosine diphosphate-ribosePoly adenosine diphosphate-ribose polymerasePoly adenosine diphosphate-ribosylationReactive oxygen species

Identifiers

PMID36158271
PMCPMC9346456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.